MIT-led team receives funding to develop a wearable monitor for early disease detection
Awarded up to $38 million from ARPA-H, the team aims to create a low-power, noninvasive sensor patch that measures heart failure and sepsis biomarkers in real-time.
An MIT-led team has received up to $38 million in funding from the U.S. Advanced Research Projects Agency for Health (ARPA-H) to develop a wearable patch for early detection of heart disease and sepsis. The project, called PYTHIA, aims to create a noninvasive device that continuously monitors biomarkers of these lethal conditions through a heat-powered chip patch.
The patch, which will capture clinical-grade health information in real time, could help clinicians diagnose heart failure and sepsis early, before irreversible damage occurs. It could also track patient recovery post-discharge and assist in developing better therapeutic approaches. PYTHIA grew out of MIT's Program for Health Sciences and Semiconductors, which focuses on using semiconductor and nanotechnology to innovate diagnostics and therapeutics.
The project's success relies on collaborations with clinical and industrial experts to address practical challenges and regulatory requirements.
Written by urgent.news from MIT News Research's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
